During the past decade, Cattedra di Ematologia CTMO Università degli Studi di Parma conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cattedra di Ematologia CTMO Università degli Studi di Parma" #1 collaborator was "ERIC Group" with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cattedra di Ematologia CTMO Università degli Studi di Parma" are "Chronic Lymphocytic Leukemia" (3 trials), "Leukemia" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Acute Promyelocytic Leukemia" (2 trials) and "Adult" (2 trials). Many other conditions were trialed in "Cattedra di Ematologia CTMO Università degli Studi di Parma" in a lesser frequency.

Most popular intervention types in "Cattedra di Ematologia CTMO Università degli Studi di Parma" are "Drug" (18 trials), "Other" (7 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (2 trials), "Observation" (2 trials), "all-trans retinoic acid (ATRA)" (2 trials), "dexamethasone" (2 trials) and "mercaptopurine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cattedra di Ematologia CTMO Università degli Studi di Parma" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cattedra di Ematologia CTMO Università degli Studi di Parma". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Cattedra di Ematologia CTMO Università degli Studi di Parma, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cattedra di Ematologia CTMO Università degli Studi di Parma, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".